According to the latest regulatory filing, Patanjali Foods Limited has received a recall order for a specific batch of cow ghee following communication from the Office of the Designated Officer, Food and Drug Administration, Burhanpur, Madhya Pradesh. The company disclosed this development through an exchange filing on Saturday, October 24, with the recall order dated October 21, 2026, and received via email on October 23, 2026. The recall order was issued by the Food and Drug Administration of Madhya Pradesh under the Food Safety and Standard Act, 2006.
The recall order was issued specifically because the cow ghee batch was deemed 'unsafe' under the regulatory framework. The communication highlighted that the sampled batch of Cow Ghee does not conform to standards set by the Regulation of Food Safety and Standards (Food Products Standards and Food Additive & Contaminants, Toxins and Residues) Regulations, 2011. This classification indicates that the product poses potential health or safety risks to consumers, prompting the FDA to take enforcement action.
According to the exchange filing, Patanjali Foods has acknowledged the recall order and provided official disclosure to stock exchanges. The company clarified that the recall pertains solely to the specific batch of Cow Ghee in question and noted that there is no material impact on its financial or operational activities beyond the value of this batch. In response to the order, Patanjali Foods intends to file an appeal against the order issued by the FDA, Burhanpur. The company confirmed that the information provided in this disclosure is accurate and complete to the best of its knowledge.
This regulatory development is being communicated to the stock exchanges as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Patanjali Foods remains committed to ensuring compliance with food safety standards and is taking steps to address the concerns raised by the FDA promptly. The company's communication through the exchange filing demonstrates its commitment to regulatory compliance and transparency regarding product safety matters.
